Print Issue: July 01, 2007

Statins Found to Decrease PSA Levels

ANAHEIM, Calif.—Statins can significantly reduce PSA levels in healthy men, and the magnitude of this decline is proportional to the extent to which the drugs reduce cholesterol levels, according to researchers.

Screening-Detected PCa May Be Less Risky

ANAHEIM, Calif.—Prostate cancers found as a result of PSA screening are less likely to exhibit extracapsular extension and positive surgical margins after radical prostatectomy than tumors found in a non-screened population, despite similar PSA levels, data show.

Positive Crossmatch Need Not Stop Tx

SAN FRANCISCO—Many renal transplant candidates who have a positive AHG-CDC crossmatch can undergo successful transplantation, a new study suggests. The study showed that only 41% of recipients with weak AHG-CDC positive crossmatches have HLA-specific donor-specific antibody (DSA).

Paricalcitol Works Safely

Paricalcitol decreases intact parathyroid hormone (iPTH) levels in children receiving hemodialysis while not causing significant changes in serum calcium, phosphorus, or Ca x P product values, a study found.

Active Surveillance A Viable Option for PCa

ANAHEIM, Calif.—Active surveillance with delayed intervention is a viable option for well-selected prostate cancer patients with favorable risk, according to researchers at the University of California in San Francisco.

Post-Cryo Salvage Difficult

Post-Cryo Salvage Difficult

ANAHEIM, Calif.—Salvage surgery may be quite problematic for patients who experience recurrence of renal cell carcinoma following primary thermal ablation, researchers reported.

Next post in World Literature Review